Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Plos One|February 6, 2013
Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptidesGal Cafri, Adi Sharbi-Yunger, Esther Tzehoval, et al.Annals of the New York Academy of Sciences|February 8, 2013
Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulinGal Cafri, Alon Margalit, Esther Tzehoval, et al.Cancer Immunology, Immunotherapy : CII|January 24, 2014
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunityZoya Alteber, Meir Azulay, Gal Cafri, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2016
Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40Noam Levin, Aviad Pato, Gal Cafri, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2015
mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor ImmunityGal Cafri, Adi Sharbi-Yunger, Esther Tzehoval, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I moleculesDikla Berko, Yaron Carmi, Gal Cafri, et al.International Immunology|June 10, 2011
Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single geneGal Cafri, Eytan Amram, Gal Rinott, et al.International Journal of Cancer|August 15, 2018
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalAdi Sharbi-Yunger, Mareike Grees, Gal Cafri, et al.Oncoimmunology|June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma modelsMareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.Pageof 2